-+ 0.00%
-+ 0.00%
-+ 0.00%

JCR Pharma (4552) 2Q operating loss turned to deficit (▲3.504 billion yen for April-September consolidated), forecasted 1.1 billion yen for March 2027

NIKKEI QUICK·10/29/2026 06:33:54

Please log in to view news